Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05582837 · ClinicalTrials.gov registry record · Phase 4
Treatment of Meniere's Disease With Migraine Medications
A Phase 4 study of Ménière, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05582837 is a Phase 4 study of Ménière that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05582837, a Phase 4 study of Ménière, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure (feeling of ear fullness), and disequilibrium (lack of stability). Vertigo represents one of the most common and distressing problems in MD patients, and it causes various somatic and psychological disorders that interfere with the patient's quality of life. Despite the large economic and emotional impact of symptoms in MD patients, there is no FDA-approved medication to treat this debilitating condition. As such, our objective in this study is to evaluate the therapeutic potential of novel medications in treating MD that have previously shown astonishing promise in our clinical practice.
Conditions Studied
Interventions
- DRUG nortriptyline + topiramate
Study Locations (1)
California
- University of California, Irvine Medical Center ENT Clinic (Pavilion 2) - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05582837
The ClinicalTrials.gov registry entry for NCT05582837 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ménière appearing as the primary indexed condition, and to 1 intervention - of which nortriptyline + topiramate is the first listed.
NCT05582837 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05582837 about?
NCT05582837 is a clinical study titled "Treatment of Meniere's Disease With Migraine Medications". Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure (feeling of ear fullness), and disequilibrium (lack of stability). Vertigo represents one of the most common and dist...
What is the current status of trial NCT05582837?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2022-08-01. Estimated completion is 2026-12-30.
What conditions does trial NCT05582837 study?
This clinical trial studies the following conditions: Ménière.
What interventions are being tested in trial NCT05582837?
The interventions under investigation include: nortriptyline + topiramate (DRUG).
Who is sponsoring clinical trial NCT05582837?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05582837 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ménière
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.